Vandetanib, an FDA-approved EGFR inhibitor, is an inexpensive drug with a low toxicity and has been used for the treatment of certain tumours of the thyroid gland.83,84 Several EGFR inhibitors have been shown to block multiple steps of replication in influenza virus85 and dengue virus.86 Therapeutic options against the various SARS-CoV2 strains are limited. The gene discussed is EGFR; the disease is thyroid tumor.